CD24 and urinary bladder carcinoma: Importantly, HIF–1α was revealed to induce CD24 mRNA expression by binding to the CD24 promoter in prostate and bladder cancer cells under hypoxia, identifying CD24 as a transcriptional target of HIF–1α and a critical downstream effector of HIF–1α–mediated survival and metastasis [36].